offline
Gilead Reports Positive Result From Key Study Of Coronavirus Drug
Gilead Sciences (GILD) said Wednesday its experimental coronavirus treatment, remdesivir, met the key goal of a study hosted by the National Institute of Allergy and Infectious Diseases.
Shares were halted in premarket trading.
+8,13 +10,5%
Gilead Sciences (GILD) said Wednesday its experimental coronavirus treatment, remdesivir, met the key goal of a study hosted by the National Institute of Allergy and Infectious Diseases.
Shares were halted in premarket trading.
+8,13 +10,5%
__________________
_________________________________________________________________________________________________
Corrections are usually over very quickly, and they're traditionally painless to long-term investors.
Experience is what you get, if you expect anything else!
Alles ist Zahl - die Vollkommenen --> 6; 28; 496; 8128; 33550336; 8589869056
Corrections are usually over very quickly, and they're traditionally painless to long-term investors.
Experience is what you get, if you expect anything else!
Alles ist Zahl - die Vollkommenen --> 6; 28; 496; 8128; 33550336; 8589869056
